Literature DB >> 7584870

Vertebral fractures and osteopenia in chronic alcoholic patients.

P Peris1, N Guañabens, A Parés, F Pons, L del Rio, A Monegal, X Surís, J Caballería, J Rodés, J Muñoz-Gómez.   

Abstract

To assess whether vertebral fractures are associated with osteopenia in chronic alcoholic patients, a transversal study was carried out in 76 chronic alcoholic males and 62 age-matched healthy males. Lumbar bone mineral density (BMD) by dual photon absorptiometry and spinal chest X-ray films were done in all patients. Twenty-seven patients (36%) had vertebral fractures, but only 5 of them had a BMD below the fracture threshold. Twenty-two patients (29%) had osteoporosis by densitometric criteria. There were no significant differences in lumbar BMD between alcoholic patients with and without vertebral fractures (1.11 +/- 0.2 versus 1.13 +/- 0.2, P = ns). Previous trauma was recorded in 24 of the 27 patients with vertebral fractures and in 28 of the 49 patients without vertebral fractures (P < 0.001). Moreover, patients with vertebral fractures had more peripheral fractures than patients without vertebral fractures (81% versus 49%, P = 0.01). Only one patient was aware of a previous episode of traumatic vertebral fracture. In conclusion, chronic alcoholics frequently have traumas and vertebral fractures, the latter despite having a lumbar BMD above the fracture threshold, suggesting a frequent but unrecognized association between both processes. These results suggest that both spine films and BMD measurements should be obtained for diagnosis of osteoporosis in alcoholic patients.

Entities:  

Mesh:

Year:  1995        PMID: 7584870     DOI: 10.1007/BF00298430

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  28 in total

1.  Current bone mass and body weight changes in alcoholic males.

Authors:  R G Crilly; L Delaquerrière-Richardson
Journal:  Calcif Tissue Int       Date:  1990-03       Impact factor: 4.333

2.  The definition and diagnosis of osteoporosis.

Authors:  B E Nordin
Journal:  Calcif Tissue Int       Date:  1987-02       Impact factor: 4.333

3.  Conditions contributing to fracture of the femoral neck.

Authors:  B E Nilsson
Journal:  Acta Chir Scand       Date:  1970

4.  Fractures on chest radiography as indicators of alcoholism in patients with liver disease.

Authors:  R D Johnson; S Davidson; J B Saunders; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-04

5.  Bone and mineral metabolism and chronic alcohol abuse.

Authors:  B C Lalor; M W France; D Powell; P H Adams; T B Counihan
Journal:  Q J Med       Date:  1986-05

Review 6.  Alcohol and bone.

Authors:  K Laitinen; M Välimäki
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

7.  Alcohol consumption and hip fractures: the Framingham Study.

Authors:  D T Felson; D P Kiel; J J Anderson; W B Kannel
Journal:  Am J Epidemiol       Date:  1988-11       Impact factor: 4.897

8.  Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study.

Authors:  M Luengo; C Picado; L Del Rio; N Guañabens; J M Montserrat; J Setoain
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

9.  Identification of alcohol abuse: thoracic fractures on routine chest X-rays as indicators of alcoholism.

Authors:  Y Israel; H Orrego; S Holt; D W Macdonald; H E Meema
Journal:  Alcohol Clin Exp Res       Date:  1980-10       Impact factor: 3.455

10.  Fracture incidence and diagnostic roentgen in alcoholics.

Authors:  H Kristensson; A Lundén; B E Nilsson
Journal:  Acta Orthop Scand       Date:  1980-04
View more
  11 in total

Review 1.  Osteodystrophy in chronic liver diseases.

Authors:  Pasquale Mansueto; Antonio Carroccio; Aurelio Seidita; Gaetana Di Fede; Antonio Craxì
Journal:  Intern Emerg Med       Date:  2012-01-13       Impact factor: 3.397

2.  Risk factors for osteoporosis in patients with end-stage liver disease.

Authors:  Shinjiro Uchida; Hisamitsu Miyaaki; Tatsuki Ichikawa; Naota Taura; Satoshi Miuma; Takuya Honda; Hidetaka Shibata; Masafumi Haraguchi; Takemasa Senoo; Kazuhiko Nakao
Journal:  Biomed Rep       Date:  2016-09-29

Review 3.  Bone disorders in chronic liver diseases.

Authors:  Bruce A Luxon
Journal:  Curr Gastroenterol Rep       Date:  2011-02

4.  Alcohol misuse in older people: heavy consumption and protean presentations.

Authors:  Milan M Mehta; Kieran J Moriarty; David Proctor; Mary Bird; Wendy Darling
Journal:  J Epidemiol Community Health       Date:  2006-12       Impact factor: 3.710

5.  Epidemiology of major osteoporotic fractures: a population-based analysis in Catalonia, Spain.

Authors:  Xavier Surís; Emili Vela; Montserrat Clèries; Maria-Jesús Pueyo-Sánchez; Esteve Llargués; Marta Larrosa
Journal:  Arch Osteoporos       Date:  2022-03-10       Impact factor: 2.617

Review 6.  Metabolic bone disease in patients with liver disease.

Authors:  Elizabeth Carey; Vijayan Balan
Journal:  Curr Gastroenterol Rep       Date:  2003-02

7.  Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol.

Authors:  C Santori; M Ceccanti; D Diacinti; M L Attilia; L Toppo; E D'Erasmo; E Romagnoli; M L Mascia; C Cipriani; A Prastaro; V Carnevale; S Minisola
Journal:  J Endocrinol Invest       Date:  2008-04       Impact factor: 4.256

Review 8.  Osteoporosis after solid organ and bone marrow transplantation.

Authors:  Adi Cohen; Elizabeth Shane
Journal:  Osteoporos Int       Date:  2003-08-08       Impact factor: 4.507

9.  Increased Bone Mineral Density after Abstinence in Male Patients with Alcohol Dependence.

Authors:  Tae-Hong Song; Joo-Cheol Shim; Do-Un Jung; Jung-Joon Moon; Dong-Wook Jeon; Sung-Jin Kim; Min-Kyung Oh
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-08-31       Impact factor: 2.582

Review 10.  An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia.

Authors:  Young Joo Yang; Dong Joon Kim
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.